1, 2016 /PRNewswire/ — Avelas Biosciences, Inc., a clinical stage ... AVB-620, will be presented at the San Antonio Breast Cancer Symposium, taking ...
News
- Avelas Announces AVB-620 Presentation at 2016 San Antonio Breast Cancer Symposium
- Biosciences company TGen joins City of Hope
PHOENIX (AP) — Phoenix biosciences company Translational Genomics Research Institute, or TGen, has become a unit of California-based City of ...
- GOP prepares for House vote on medical research bill
Government drug approvals would be accelerated, there would be more money for biomedical research — including on cancer, a priority for the White ...
- Sen. Warren blasts drug approval bill as 'extortion'
Those provisions, she said, outweighed the "tiny fig leaf" of additional money the bill provides for biomedical research and combating abuse of ...
- Research Reports Initiation on Biotech Stocks -- ImmunoGen, Puma Biotech, Arrowhead Pharma ...
On Friday, November 25th, 2016, the iShares NASDAQ Biotechnology Index ... Cancer Symposium, December 6th-10th, 2016, in San Antonio, Texas.